|
New York, NY, November 18, 2009,T12-NEWS reports that Revenue for GTC Biotherapeutics (NASDAQ:GTCB) for its trailing twelve months (TTM) ended September 30, 2009 was $2,645,000, a -85.83% decrease ove ... read full story |
|
| Website Address: |
www.gtc-bio.com |
| Industry: |
Biomaterial & Tissue Engineering
|
|